XGN logo

Exagen (XGN) Cash And Cash Equivalents

Annual Cash & Cash Equivalents

$36.49 M
-$25.90 M-41.51%

December 31, 2023


Summary


Performance

XGN Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherXGNbalance sheetmetrics:

Quarterly Cash And Cash Equivalents

$22.04 M
-$2.44 M-9.98%

September 30, 2024


Summary


Performance

XGN Quarterly Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherXGNbalance sheetmetrics:

Cash And Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

XGN Cash And Cash Equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-41.5%-22.5%
3 y3 years-36.5%-79.4%
5 y5 years+177.2%-64.1%

XGN Cash And Cash Equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-63.3%at low-77.8%at low
5 y5-year-63.3%at low-81.3%at low
alltimeall time-63.3%+1354.5%-81.3%+778.2%

Exagen Cash And Cash Equivalents History

DateAnnualQuarterly
Sep 2024
-
$22.04 M(-10.0%)
Jun 2024
-
$24.48 M(-10.2%)
Mar 2024
-
$27.27 M(-25.3%)
Dec 2023
$36.49 M(-41.5%)
$36.49 M(+28.3%)
Sep 2023
-
$28.45 M(-9.6%)
Jun 2023
-
$31.47 M(-39.7%)
Mar 2023
-
$52.18 M(-16.4%)
Dec 2022
$62.39 M(-37.3%)
$62.39 M(-9.2%)
Sep 2022
-
$68.70 M(-10.1%)
Jun 2022
-
$76.39 M(-14.9%)
Mar 2022
-
$89.75 M(-9.7%)
Dec 2021
$99.44 M(+73.1%)
$99.44 M(-6.9%)
Sep 2021
-
$106.77 M(-5.2%)
Jun 2021
-
$112.58 M(-4.6%)
Mar 2021
-
$118.05 M(+105.5%)
Dec 2020
$57.45 M
$57.45 M(-6.5%)
DateAnnualQuarterly
Sep 2020
-
$61.43 M(-3.6%)
Jun 2020
-
$63.70 M(-7.2%)
Mar 2020
-
$68.65 M(-4.8%)
Dec 2019
$72.08 M(+447.6%)
$72.08 M(-7.4%)
Sep 2019
-
$77.83 M(+379.3%)
Jun 2019
-
$16.24 M(+23.3%)
Dec 2018
$13.16 M(+17.1%)
$13.16 M(+424.7%)
Dec 2017
$11.24 M(+348.0%)
-
Dec 2015
$2.51 M(-45.5%)
$2.51 M(-8.3%)
Sep 2015
-
$2.74 M(-6.2%)
Jun 2015
-
$2.92 M(-16.6%)
Mar 2015
-
$3.50 M(-24.0%)
Dec 2014
$4.61 M(-40.5%)
$4.61 M(-35.4%)
Sep 2014
-
$7.12 M(+16.4%)
Jun 2014
-
$6.12 M(-21.0%)
Dec 2013
$7.74 M(+182.1%)
$7.74 M
Dec 2012
$2.75 M
-

FAQ

  • What is Exagen annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Exagen?
  • What is Exagen annual cash & cash equivalents year-on-year change?
  • What is Exagen quarterly cash and cash equivalents?
  • What is the all time high quarterly cash and cash equivalents for Exagen?
  • What is Exagen quarterly cash and cash equivalents year-on-year change?

What is Exagen annual cash & cash equivalents?

The current annual cash & cash equivalents of XGN is $36.49 M

What is the all time high annual cash & cash equivalents for Exagen?

Exagen all-time high annual cash & cash equivalents is $99.44 M

What is Exagen annual cash & cash equivalents year-on-year change?

Over the past year, XGN annual cash & cash equivalents has changed by -$25.90 M (-41.51%)

What is Exagen quarterly cash and cash equivalents?

The current quarterly cash and cash equivalents of XGN is $22.04 M

What is the all time high quarterly cash and cash equivalents for Exagen?

Exagen all-time high quarterly cash and cash equivalents is $118.05 M

What is Exagen quarterly cash and cash equivalents year-on-year change?

Over the past year, XGN quarterly cash and cash equivalents has changed by -$6.41 M (-22.54%)